Option Care Health, Inc. (OPCH)
Healthcare · NMS
Price as at 1 Oct 2026, 15:07 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Option Care Health, Inc. trades at $22.56, which is 63% below the $36.76 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 31 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 17.4 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
OPCH dividend history
No individual payments are on record for this listing, so the current facts above are all we can honestly show.
OPCH earnings and analyst estimates
Recommendation mix, 13 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
OPCH passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
11 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Henry Ellenbogen, Durable Capital Partners LP$129.25M · 1.3% of book
- Arrowstreet Capital, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$125.41M · 0.1% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$54.92M · 0.0% of book
- Steve Cohen, Point72 Asset Management, L.P.$37.75M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$34.26M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
OPCH peers
The largest companies in the same industry (Medical Care Facilities), then in the same sector.
- FSNUY Fresenius SE & Co. KGaA
- THC Tenet Healthcare Corporation
- FMS Fresenius Medical Care AG
- ENSG The Ensign Group, Inc.
- UHS Universal Health Services, Inc.
- RHC.AX Ramsay Health Care Limited
- CHE Chemed Corporation
- CON Concentra Group Holdings Parent, Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Option Care Health, Inc. (OPCH) undervalued?
Against our fair value estimate of $36.76, OPCH at $22.56 is 63% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own OPCH?
11 of the institutions we track reported a position in OPCH in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
What is OPCH's P/E ratio?
OPCH trades at 17.4 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
When does OPCH report earnings next?
Option Care Health, Inc. is scheduled to report on 29 Oct 2026. Companies move earnings dates, so read it as scheduled rather than certain.
Where does SteadyShares get its OPCH data?
Fundamentals for OPCH come from company filings and exchange data, as listed on NMS; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 15:07 UTC and is delayed. Our data quality score for this company is 96/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for OPCH, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.